JMS Co

JMS Co EBIT per Employee

The EBIT per Employee of JMS Co (7702.T) as of Nov 3, 2026 is 67,787.61 JPY. In the previous year, EBIT per Employee was 154,690.27 JPY — a change of -56.18% (lower).

EBIT per Employee

67,787.61JPY

YoY

-56.18%

Last updated:

EBIT per Employee of JMS Co is 2026 67,787.61 JPY. EBIT per Employee of JMS Co was 2025 154,690.27 JPY. It decreases by -56.18% lower compared to the previous year.

The JMS Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
259,115.04 JPY
Jan 1, 2020
441,061.95 JPY
Jan 1, 2021
405,840.71 JPY
Jan 1, 2022
173,451.33 JPY
Jan 1, 2023
128,141.59 JPY
Jan 1, 2024
64,778.76 JPY
Jan 1, 2025
154,690.27 JPY
Jan 1, 2026
67,787.61 JPY
The JMS Co EBIT per Employee history
YEAREBIT per EmployeeYoY
67,787.61JPY-56.18%
154,690.27JPY+138.80%
64,778.76JPY-49.45%
128,141.59JPY-26.12%
173,451.33JPY-57.26%
405,840.71JPY-7.99%
441,061.95JPY+70.22%
259,115.04JPY+54.59%
167,610.62JPY-14.38%
195,752.21JPY-22.22%
251,681.42JPY+276.19%
66,902.65JPY-58.00%
159,292.04JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

EBIT per Employee of JMS Co is 67,787.61 JPY in 2026.

EBIT per Employee of JMS Co changed from 154,690.27 JPY to 67,787.61 JPY, representing a -56.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee JMS Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's JMS Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — JMS Co

All Key Metrics — JMS Co